We Changed, We Led, We Conquered

• by Helen Bristow

• August 26, 2026

FDA expands gastroesophageal cancer options

Phase 3 findings showed longer median progression-free survival with zanidatamab-containing regimens vs trastuzumab plus chemotherapy.

• by Kathryn Wighton

• August 25, 2026

• 2 min

Innovative pathological and therapeutic approaches for poorly cohesive gastric cancer

• by Margherita Muratore, Francesco Giulio Sullo, Alessandro Bittoni, Lina Cardisciani, Martina Valgiusti, Giulia Bartolini, Luca Esposito, Chiara Molinari, Richard Camara, Alessandro Passardi

• August 25, 2026

Your Genes May Shape Tumor Evolution

Mouse study links inherited genetics to driver mutation selection, genome stability, and tumor evolution

• August 19, 2026

• 3 min